Although KLF4 and its several downstream targets have been well dissected, especially in gastrointestinal and pancreatic cancer, it remains unclear why elevated KLF4 protein levels enhance malignant transformation in the mammary glands and skin1, 7. This evidence concerns the gene KLF4 and pancreatic neoplasm.